The Conjugation and Labeling Services Market is projected to grow at a CAGR of 10%, till 2035, according to a new market research report by Roots Analysis

A number of drug developers and research institutes currently lack the technical expertise related to bioconjugation chemistries, along with limited in-house capabilities and scarcity of advanced bioconjugation technologies, which are essential to carry out the process of conjugation. In order to leverage the relevant experience and expertise of service providers, several organizations prefer to outsource their antibody conjugation services and protein labeling operations. Additionally, various stakeholders have been making consolidated efforts to forge alliance with other industry / non-industry players. It is worth highlighting that, since 2018, over 70 strategic partnerships have been inked, indicating that service providers are actively upgrading their conjugation related capabilities and accommodating the current and anticipated demand for bioconjugates. In fact, in July 2023, Novartis announced the acquisition of DTx Pharma with an aim to utilize its proprietary FALCON platform…

A number of drug developers and research institutes currently lack the technical expertise related to bioconjugation chemistries, along with limited in-house capabilities and scarcity of advanced bioconjugation technologies, which are essential to carry out the process of conjugation. In order to leverage the relevant experience and expertise of service providers, several organizations prefer to outsource their antibody conjugation services and protein labeling operations. Additionally, various stakeholders have been making consolidated efforts to forge alliance with other industry / non-industry players. It is worth highlighting that, since 2018, over 70 strategic partnerships have been inked, indicating that service providers are actively upgrading their conjugation related capabilities and accommodating the current and anticipated demand for bioconjugates. In fact, in July 2023, Novartis announced the acquisition of DTx Pharma with an aim to utilize its proprietary FALCON platform to develop siRNA therapies that can be used for the treatment of various neurological indications.

To order this 220+ page report, which features 60+ figures and 70+ tables, please visit our report on Conjugation and Labelling Services Market

Key Market Insights

For more information, please visit https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market.html

The financial opportunity within the conjugation and labeling services market has been analyzed across the following segments:

The opinions and insights presented in the report were influenced by discussions held with stakeholders in this domain. The report features detailed transcripts of interviews held with the following industry stakeholders:

The research includes brief profiles of key players (listed below) offering conjugation and labeling services; each profile features a brief overview of the company, recent developments and an informed future outlook.

Key Questions Answered

Table of Contents

For additional details, please visit https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market.html or email sales@rootsanalysis.com  

You may also be interested in the following titles:

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
gaurav.chaudhary@rootsanalysis.com

Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/the-conjugation-and-labeling-services-market-is-projected-to-grow-at-a-cagr-of-10-till-2035-according-to-a-new-market-research-report-by-roots-analysis-301918062.html